|
WO1981001145A1
(en)
|
1979-10-18 |
1981-04-30 |
Univ Illinois |
Hydrolytic enzyme-activatible pro-drugs
|
|
US4698420A
(en)
|
1985-02-25 |
1987-10-06 |
Xoma Corporation |
Antibody hybrid molecules and process for their preparation
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
ES2232871T3
(es)
|
1996-07-03 |
2005-06-01 |
Sumitomo Pharmaceuticals Company, Limited |
Nuevos derivados de purina.
|
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
|
US7425541B2
(en)
|
1998-12-11 |
2008-09-16 |
Medarex, Inc. |
Enzyme-cleavable prodrug compounds
|
|
EP1212422B1
(en)
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
|
AU2001286727A1
(en)
|
2000-08-24 |
2002-03-04 |
Coulter Pharmaceutical, Inc. |
Prodrugs activated by plasmin and their use in cancer chemotherapy
|
|
US7571211B1
(en)
|
2002-04-15 |
2009-08-04 |
Lightwaves Systems, Inc. |
Method for routing messages over a network based on location
|
|
US7157465B2
(en)
|
2001-04-17 |
2007-01-02 |
Dainippon Simitomo Pharma Co., Ltd. |
Adenine derivatives
|
|
US6989452B2
(en)
|
2001-05-31 |
2006-01-24 |
Medarex, Inc. |
Disulfide prodrugs and linkers and stabilizers useful therefor
|
|
WO2002100353A2
(en)
|
2001-06-11 |
2002-12-19 |
Medarex, Inc. |
Cd10-activated prodrug compounds
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
WO2003037860A2
(en)
|
2001-10-30 |
2003-05-08 |
Conforma Therapeutics Corporation |
Purine analogs having hsp90-inhibiting activity
|
|
IL162835A0
(en)
|
2002-01-09 |
2005-11-20 |
Medarex Inc |
Human monoclonal antibodies against cd30
|
|
MXPA05003193A
(es)
|
2002-09-27 |
2005-06-08 |
Sumitomo Pharma |
Compuesto de adenina novedoso y uso del mismo.
|
|
JP2004137157A
(ja)
|
2002-10-16 |
2004-05-13 |
Sumitomo Pharmaceut Co Ltd |
新規アデニン誘導体を有効成分として含有する医薬
|
|
EP2261244A3
(en)
|
2003-04-15 |
2011-02-23 |
Glaxosmithkline LLC |
Human il-18 substitution mutants and their conjugates
|
|
MXPA06000798A
(es)
|
2003-07-22 |
2006-04-07 |
Schering Ag |
Anticuerpos de rg1 y usos de los mismos.
|
|
WO2005051976A2
(en)
|
2003-11-20 |
2005-06-09 |
Ansata Therapeutics, Inc. |
Protein and peptide ligation processes and one-step purification processes
|
|
PL1691837T3
(pl)
|
2003-12-10 |
2012-11-30 |
Squibb & Sons Llc |
IP-10 przeciwciała i ich zastosowanie
|
|
CA2556752C
(en)
|
2004-02-23 |
2016-02-02 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
EP1737890A2
(en)
|
2004-03-24 |
2007-01-03 |
Xencor, Inc. |
Immunoglobulin variants outside the fc region
|
|
WO2005092892A1
(ja)
|
2004-03-26 |
2005-10-06 |
Dainippon Sumitomo Pharma Co., Ltd. |
８−オキソアデニン化合物
|
|
JP4806680B2
(ja)
|
2004-05-19 |
2011-11-02 |
メダレックス インコーポレイテッド |
自己犠牲リンカー及び薬剤複合体
|
|
US7691962B2
(en)
|
2004-05-19 |
2010-04-06 |
Medarex, Inc. |
Chemical linkers and conjugates thereof
|
|
DK1791565T3
(en)
|
2004-09-23 |
2016-08-01 |
Genentech Inc |
Cysteingensplejsede antibodies and conjugates
|
|
EP1809632A2
(en)
|
2004-10-28 |
2007-07-25 |
Pharmacia & Upjohn Company LLC |
Pyrazolo[4,3-d]pyrimidine derivatives useful as pde-5 inhibitors
|
|
JP2008529556A
(ja)
|
2005-02-18 |
2008-08-07 |
メダレックス， インク． |
前立腺特異的膜抗原（ｐｓｍａ）に対するヒトモノクローナル抗体
|
|
CN101160324B
(zh)
|
2005-02-18 |
2013-04-24 |
米德列斯公司 |
缺乏岩藻糖残基的抗前列腺特异性膜抗原(psma)单克隆抗体
|
|
US7714016B2
(en)
|
2005-04-08 |
2010-05-11 |
Medarex, Inc. |
Cytotoxic compounds and conjugates with cleavable substrates
|
|
AU2006242920A1
(en)
|
2005-05-04 |
2006-11-09 |
Pfizer Limited |
2-amido-6-amino-8-oxopurine derivatives as Toll-Like receptor modulators for the treatment of cancer and viral infections, such as hepatitis C
|
|
DK2439273T3
(da)
|
2005-05-09 |
2019-06-03 |
Ono Pharmaceutical Co |
Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
|
|
CA2611814A1
(en)
|
2005-06-20 |
2007-01-04 |
Medarex, Inc. |
Cd19 antibodies and their uses
|
|
PT1907424E
(pt)
|
2005-07-01 |
2015-10-09 |
Squibb & Sons Llc |
Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1)
|
|
DK3248613T3
(da)
|
2005-07-18 |
2022-03-14 |
Seagen Inc |
Beta-glucuronid-lægemiddel-linkerkonjugater
|
|
JP4584335B2
(ja)
|
2005-09-02 |
2010-11-17 |
ファイザー・インク |
ヒドロキシ置換１ｈ−イミダゾピリジンおよび方法
|
|
US20090105212A1
(en)
|
2005-09-22 |
2009-04-23 |
Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan |
Novel adenine compound
|
|
JPWO2007034817A1
(ja)
|
2005-09-22 |
2009-03-26 |
大日本住友製薬株式会社 |
新規アデニン化合物
|
|
EP2354163A3
(en)
|
2005-09-26 |
2013-04-24 |
Medarex, Inc. |
Conjugates of duocarmycin and anti-CD70 or anti-PSMA antibodies
|
|
NZ566395A
(en)
|
2005-09-26 |
2012-03-30 |
Medarex Inc |
Human monoclonal antibodies to CD70
|
|
RS52100B
(sr)
|
2005-10-26 |
2012-06-30 |
Medarex, Inc. |
Postupci i jedinjenja za pripremu analoga cc-1065
|
|
WO2007059404A2
(en)
|
2005-11-10 |
2007-05-24 |
Medarex, Inc. |
Duocarmycin derivatives as novel cytotoxic compounds and conjugates
|
|
WO2007067991A2
(en)
|
2005-12-08 |
2007-06-14 |
Medarex, Inc. |
Human monoclonal antibodies to o8e
|
|
EA017812B1
(ru)
|
2005-12-08 |
2013-03-29 |
Медарекс, Инк. |
Выделенное моноклональное антитело или его антигенсвязывающий участок, которые связываются с протеинтирозинкиназой 7 ( ptk7) человека, и их применение
|
|
JP2009528989A
(ja)
|
2006-02-17 |
2009-08-13 |
ファイザー・リミテッド |
Ｔｌｒ７変調剤としての３−デアザプリン誘導体
|
|
WO2008066583A2
(en)
|
2006-06-29 |
2008-06-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-free synthesis of proteins containing unnatural amino acids
|
|
WO2008020075A1
(en)
|
2006-08-18 |
2008-02-21 |
Novo Nordisk Health Care Ag |
Transglutaminase variants with improved specificity
|
|
JP2010502221A
(ja)
|
2006-09-08 |
2010-01-28 |
アンブルックス，インコーポレイテッド |
脊椎動物細胞による非天然アミノ酸の部位特異的組み込み
|
|
MX2009003306A
(es)
|
2006-10-02 |
2009-04-23 |
Medarex Inc |
Anticuerpos humanos que se unen a cxcr4 y sus usos.
|
|
US8481683B2
(en)
|
2006-12-01 |
2013-07-09 |
Medarex, Inc. |
Human antibodies that bind CD22 and uses thereof
|
|
UY30776A1
(es)
|
2006-12-21 |
2008-07-03 |
Medarex Inc |
Anticuerpos cd44
|
|
TWI412367B
(zh)
|
2006-12-28 |
2013-10-21 |
梅達雷克斯有限責任公司 |
化學鏈接劑與可裂解基質以及其之綴合物
|
|
CN101790380B
(zh)
|
2007-02-07 |
2013-07-10 |
加利福尼亚大学董事会 |
合成tlr激动剂的缀合物及其应用
|
|
AR065404A1
(es)
|
2007-02-21 |
2009-06-03 |
Medarex Inc |
Conjugados farmaco-ligando, los que se unen a citotoxinas potentes, composicion farmaceutica que los contienen y su uso para retardar o detener el crecimiento de un tumor en un mamifero
|
|
US20100087371A1
(en)
|
2007-02-22 |
2010-04-08 |
Sean Hu |
Transglutaminase Variants with Improved Specificity
|
|
AR065784A1
(es)
|
2007-03-20 |
2009-07-01 |
Dainippon Sumitomo Pharma Co |
Derivados de 8-oxo adenina,medicamentos que los contienen y usos como agentes terapeuticos para enfermedades alergicas, antivirales o antibacterianas.
|
|
EP2132207A2
(en)
|
2007-03-23 |
2009-12-16 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
CA2691444C
(en)
|
2007-06-29 |
2016-06-14 |
Gilead Sciences, Inc. |
Purine derivatives and their use as modulators of toll-like receptor 7
|
|
ES2359123T3
(es)
|
2007-08-03 |
2011-05-18 |
Pfizer Limited |
Imidazopiridinonas.
|
|
US8865875B2
(en)
|
2007-08-22 |
2014-10-21 |
Medarex, L.L.C. |
Site-specific attachment of drugs or other agents to engineered antibodies with C-terminal extensions
|
|
ES2526355T3
(es)
|
2007-10-01 |
2015-01-09 |
Bristol-Myers Squibb Company |
Anticuerpos humanos que se adhieren a mesotelina, y usos de los mismos
|
|
RS53347B
(sr)
|
2008-12-09 |
2014-10-31 |
Gilead Sciences, Inc. |
Modulatori toll-sličnih receptora
|
|
WO2010087994A2
(en)
|
2009-01-30 |
2010-08-05 |
Whitehead Institute For Biomedical Research |
Methods for ligation and uses thereof
|
|
KR20110117705A
(ko)
|
2009-02-11 |
2011-10-27 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
톨-유사 수용체 조정제 및 질병의 치료
|
|
JP5694345B2
(ja)
|
2009-10-22 |
2015-04-01 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｔｏｌｌ様受容体の調節因子
|
|
JP2013525431A
(ja)
|
2010-04-30 |
2013-06-20 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
合成ｔｌｒ７アゴニストのリン脂質結合体の使用
|
|
AU2011247358B2
(en)
|
2010-04-30 |
2014-10-30 |
Urogen Pharma Ltd. |
Phospholipid drug analogs
|
|
US20120003298A1
(en)
|
2010-04-30 |
2012-01-05 |
Alcide Barberis |
Methods for inducing an immune response
|
|
WO2012038058A1
(en)
|
2010-09-21 |
2012-03-29 |
Telormedix Sa |
Treatment of conditions by toll-like receptor modulators
|
|
CA2813411C
(en)
|
2010-11-05 |
2016-08-02 |
Rinat Neuroscience Corporation |
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
|
|
TW201247706A
(en)
|
2011-03-08 |
2012-12-01 |
Baylor Res Inst |
Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
|
|
KR20140050698A
(ko)
|
2011-07-29 |
2014-04-29 |
셀렉타 바이오사이언시즈, 인크. |
체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
|
|
JP6349256B2
(ja)
|
2011-11-09 |
2018-06-27 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染の治療のためのプリン誘導体
|
|
EA035790B1
(ru)
|
2012-07-13 |
2020-08-11 |
Янссен Сайенсиз Айрлэнд Юси |
Макроциклические пурины для лечения вирусных инфекций
|
|
EA026354B1
(ru)
|
2012-08-24 |
2017-03-31 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
Пиразолопиримидиновые соединения
|
|
DK2906563T3
(en)
|
2012-10-10 |
2018-06-06 |
Janssen Sciences Ireland Uc |
PYRROLO [3,2-D] PYRIMIDINE DERIVATIVES FOR TREATING VIRUS INFECTIONS AND OTHER DISEASES
|
|
EP2732825B1
(en)
|
2012-11-19 |
2015-07-01 |
Invivogen |
Conjugates of a TLR7 and/or TLR8 agonist and a TLR2 agonist
|
|
LT2956173T
(lt)
|
2013-02-14 |
2017-06-26 |
Bristol-Myers Squibb Company |
Tubulizino junginiai, gavimo ir panaudojimo būdai
|
|
US9295732B2
(en)
|
2013-02-22 |
2016-03-29 |
Invivogen |
Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists
|
|
CN110590809B
(zh)
|
2013-03-29 |
2022-04-19 |
爱尔兰詹森科学公司 |
用于治疗病毒感染的大环脱氮-嘌呤酮
|
|
PT3030563T
(pt)
|
2013-06-27 |
2017-11-15 |
Janssen Sciences Ireland Uc |
Derivados de pirrolo[3,2-d]pirimidina para o tratamento de infeções virais e outras doenças
|
|
EP3033089A2
(en)
|
2013-08-16 |
2016-06-22 |
The Regents of The University of California |
Uses of phospholipid conjugates of synthetic tlr7 agonists
|
|
WO2015036044A1
(en)
|
2013-09-13 |
2015-03-19 |
Telormedix Sa |
Cationic lipid vehicles for delivery of tlr7 agonists for specific targeting of human cd14+ monocytes in whole blood
|
|
CN107001354B
(zh)
*
|
2014-04-11 |
2021-06-22 |
台北医学大学 |
组蛋白去乙酰酶抑制剂
|
|
ES2908150T3
(es)
|
2014-05-01 |
2022-04-27 |
Novartis Ag |
Compuestos y composiciones como agonistas del receptor de tipo Toll 7
|
|
PL3137470T3
(pl)
|
2014-05-01 |
2021-10-11 |
Novartis Ag |
Związki i kompozycje jako agonisty receptora toll-like 7
|
|
WO2015171527A1
(en)
*
|
2014-05-05 |
2015-11-12 |
Global Blood Therapeutics, Inc. |
Pyrazolopyridine pyrazolopyrimidine and related compounds
|
|
KR20170002623A
(ko)
*
|
2014-05-14 |
2017-01-06 |
화이자 인코포레이티드 |
피라졸로피리딘 및 피라졸로피리미딘
|
|
HRP20210927T1
(hr)
|
2014-08-15 |
2021-09-03 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Spojevi pirolopirimidina koje se koriste kao agonist tlr7
|
|
CN105367576A
(zh)
*
|
2014-08-15 |
2016-03-02 |
正大天晴药业集团股份有限公司 |
作为tlr7激动剂的吡咯并嘧啶化合物
|
|
UY36391A
(es)
*
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
|
|
CN105732635A
(zh)
|
2014-12-29 |
2016-07-06 |
南京明德新药研发股份有限公司 |
一类Toll样受体7激动剂
|
|
JP2018510864A
(ja)
|
2015-03-10 |
2018-04-19 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
トランスグルタミナーゼによって結合可能な抗体およびそれによって製造される結合体
|
|
JP2018524372A
(ja)
*
|
2015-07-15 |
2018-08-30 |
アウリジーン ディスカバリー テクノロジーズ リミテッド |
Ｉｒａｋ−４阻害剤としてのインダゾール及びアザインダゾール化合物
|
|
JP2018531935A
(ja)
|
2015-10-02 |
2018-11-01 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
抗体を結合させるためのトランスグルタミナーゼバリアント
|
|
EP3368092B9
(en)
*
|
2015-10-29 |
2020-07-29 |
Novartis AG |
Antibody conjugates comprising toll-like receptor agonist
|
|
UA121345C2
(uk)
|
2015-11-05 |
2020-05-12 |
Чіа Тай Тяньцин Фармасьютікал Груп Ко., Лтд. |
7-(тіазол-5-іл)піролопіримідин як агоніст рецептора tlr7
|
|
WO2017100557A1
(en)
|
2015-12-11 |
2017-06-15 |
Graphic Packaging International, Inc. |
Container with absorption features
|
|
WO2017197056A1
(en)
*
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Bromodomain targeting degronimers for target protein degradation
|
|
CA3025746A1
(en)
|
2016-06-16 |
2017-12-21 |
Janssen Pharmaceutica Nv |
Azabenzimidazole derivatives as pi3k beta inhibitors
|
|
EP3512556B1
(en)
*
|
2016-09-13 |
2021-08-18 |
F. Hoffmann-La Roche AG |
Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor
|
|
WO2018095426A1
(zh)
|
2016-11-28 |
2018-05-31 |
江苏恒瑞医药股份有限公司 |
吡唑并杂芳基类衍生物、其制备方法及其在医药上的应用
|
|
US10457681B2
(en)
|
2017-08-16 |
2019-10-29 |
Bristol_Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor
|
|
US10494370B2
(en)
|
2017-08-16 |
2019-12-03 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
|
|
US10487084B2
(en)
|
2017-08-16 |
2019-11-26 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
|
|
US10508115B2
(en)
|
2017-08-16 |
2019-12-17 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
|
|
US10472361B2
(en)
|
2017-08-16 |
2019-11-12 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor
|
|
CN111757755A
(zh)
|
2017-12-21 |
2020-10-09 |
大日本住友制药株式会社 |
包含tlr7激动剂的组合药物
|
|
WO2019209811A1
(en)
|
2018-04-24 |
2019-10-31 |
Bristol-Myers Squibb Company |
Macrocyclic toll-like receptor 7 (tlr7) agonists
|
|
US11554120B2
(en)
*
|
2018-08-03 |
2023-01-17 |
Bristol-Myers Squibb Company |
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
|
|
US11664120B1
(en)
*
|
2020-05-11 |
2023-05-30 |
Walgreen Co. |
Apparatuses, systems, and methods for reducing return of prescriptions to stock
|